Omixon at the EFI Annual Meeting 2019

30/04/2019

Omixon announces today that Holotype HLA and other Omixon products will be featured in 12 poster presentations at the annual meeting of the European Federation for Immunogenetics (EFI) in Lisbon, Portugal. Among the major scientific events, Omixon’s Lunch Symposium on Thursday will focus on HLA typing for disease associations...

New Approaches in HLA Matching – PIRCHE

29/04/2019

Authors: Libor Kolesar, Matthias Niemann, Efi Melista INTRODUCTION In the previous blog post we talked about a hot topic in the HLA community right now which is the one of epitope-based matching. We discussed one of the methodologies that are commonly used, HLA Matchmaker, and this time we will...

Davide Resio Joins Omixon as Sales Manager for EMEA

25/04/2019

Please join us in welcoming Davide Resio as our new Sales Manager for EMEA! Davide graduated in Industrial Biotechnology in Milan with a thesis on the role of inhibitors of histone deacetylases in inflammation. He started his career in sales at Millipore where he was responsible for filtration business...

Join Omixon for our Lunchtime Symposium at EFI 2019!

16/04/2019

Omixon is pleased to announce our Symposium at the 2019 EFI Meeting in Lisbon, Portugal which will focus on HLA typing in disease associations using NGS, featuring two guest speakers, Dr. Mohamed Jahromi (Dasman Diabetes Institute, Kuwait) and Professor Mehdi Tafti (University of Lausanne, Switzerland). Additionally, Omixon’s Head of Product, Efi Melista...

Omixon Awarded the Hungarian Innovation Grand Prize 2018

29/03/2019

We are extremely happy and honored to share the news that Omixon got awarded the Hungarian Innovation Grand Prize 2018 at the Hungarian Parliament. This is such a great achievement and we are thankful to everyone being involved in our success. We are proud of our team and...